Clinically amyopathic dermatomyositis with interstitial lung disease double-positive for anti-MDA5 and anti-PL12 antibodies
Open Access
- 18 February 2022
- journal article
- research article
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 36, 101606
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Common and Distinct Clinical Features in Adult Patients with Anti-Aminoacyl-tRNA Synthetase Antibodies: Heterogeneity within the SyndromePLOS ONE, 2013
- Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositisRheumatology, 2012
- Hyperferritinaemia and macrophage activation in a patient with interstitial lung disease with clinically amyopathic DMRheumatology, 2012
- HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibodyRespiratory Medicine, 2011
- Clinically amyopathic dermatomyositisCurrent Opinion in Rheumatology, 2010
- Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositisRheumatology, 2010
- Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositisRheumatology, 2010
- Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expressionRheumatology, 2009
- Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathiesAutoimmunity, 2006
- Autoantibodies to a 140‐kd polypeptide, CADM‐140, in Japanese patients with clinically amyopathic dermatomyositisArthritis & Rheumatism, 2005